« Return to News | Drug Sponsors

Mylan expands in Ireland, creates 500 jobs

Wednesday, April 18, 2012 02:54 PM

Mylan, a generics and specialty pharmaceutical company based in Canonsburg, Penn., will expand its operations in Dublin and Galway, Ireland, by investing up to $100 million over the next five years.

The investment will fund expanded R&D and manufacturing capabilities within the company's respiratory, injectables and oral solids franchises. In addition, with support from the Irish Development Authority (IDA), Myland will add more than 500 new positions to its Ireland-based workforce by 2016.

"The expansion of Mylan's operations in Ireland is an extremely positive development for Ireland's life sciences sector,” said Barry O'Leary, CEO of IDA. “These projects meet with key objectives of IDA Ireland's strategy Horizon 2020 to create high quality life sciences jobs. I wish Mylan every success with this operation and on behalf of IDA Ireland look forward to continuing to work closely and support the company in the future.''

Mylan's operations in Ireland include Gerard Laboratories and Bioniche Pharma.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.